The FDA approved mitapivat for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. Pyruvate kinase (PK) deficiency is a rare inherited disorder that causes anemia via the ...

Deficient activity of erythrocyte and leukocyte glucosephosphate isomerase was found in three siblings with hereditary hemolytic anemia who were unrelated to the single patient previously described.

Anemia is the most prevalent blood condition in the U.S. Annually, the condition accounts for 2.8 million visits to physician offices with anemia as the primary diagnosis, according to the Centers for ...

A new drug that is both the first in its class and the first disease-modifying agent for hemolytic anemia in adults with pyruvate kinase (PK) deficiency has been approved by the US Food and Drug ...

The FDA has approved Pyrukynd (mitapivat) for the treatment of hemolytic anemia in adults with pyruvate kinase deficiency. The Food and Drug Administration (FDA) has approved Pyrukynd ® (mitapivat) ...

Spherocytosis, otherwise known as hereditary spherocytosis, is an inherited blood disorder that causes red blood cells to become sphere-shaped (spherocytes) rather than their normal disk shape.

Clinical Infectious Diseases publishes clinically relevant articles on the pathogenesis, clinical investigation, medical microbiology, diagnosis, immune mechanisms, and treatment of diseases caused by ...

B. Ibarra, G. Vaca, E. de la Mora, F. Romero, C. Aguilar-Luna, A. Mejía, M.A. Esparza, G. Pérez, M.L. Ornelas and J.M. Cantú Twenty-eight Hb abnormalities (16 ...

Cold antibody hemolytic anemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells by autoantibodies at temperatures of approximately 0 to 10 degrees Celsius. Q ...